Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 14, 2016

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions

Myomectomy; Surgical Blood Loss

Interventions

DRUG

Misoprostol 200Mcg Tab

4 tablets will be inserted rectally

DRUG

Placebo

Trial Locations (3)

St. Lukes Baptist Hospital, San Antonio

University Hospital, San Antonio

University of Texas Health Science Center, San Antonio

All Listed Sponsors

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT03064568 - Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy | Biotech Hunter | Biotech Hunter